医学
代谢综合征
血脂异常
疾病
病态的
肥胖
糖尿病
重症监护医学
2型糖尿病
2型糖尿病
生物信息学
儿科
内科学
内分泌学
生物
作者
Lauren L. Schnack,Andrea Romani
出处
期刊:Recent Patents on Biotechnology
[Bentham Science]
日期:2017-02-28
卷期号:11 (2)
被引量:10
标识
DOI:10.2174/1872208311666170227112013
摘要
Background: Metabolic Syndrome is a pathological condition characterized by the copresence of various dysmetabolic and pathological processes including hypertension, dyslipidemia, type 2 diabetes mellitus, obesity, and cardiovascular complications. Because these conditions manifest themselves differently in a given patient, the ensuing pathophysiological state varies from patient to patient. Consequently, the order in which signs and symptoms manifest themselves can vary, making difficult to establish cause-effect relationship, and efficacious treatment and prevention options. Furthermore, the available therapeutic options do not necessarily apply in an effective manner to all patients due to the modality of the syndrome’s onset and progression, and the fact that each patient presents different clinical manifestations. Results: Where do the metabolic disturbances originate? Genetic predisposition, maternal health, age, and ethnicity are possible influential factors, which put individuals at higher risk for developing metabolic defects. More recently, dietary factors and deficiency in key macro- and micro-nutrients have been indicated as key players in the onset and progression of the disease. We revised all possible patents applying to this topic. Aside from pharmacological agents used to treat specific medical conditions, no patents were observed to be registered for specific dietary macro- and micro-nutrients. Conclusion: The present review attempts to provide a framework to help the reader understand the causes behind the development of the metabolic syndrome and its complication. Keywords: Metabolic syndrome, obesity, cardiovascular diseases, type 2 diabetes mellitus, dietary protein deficiency, hypomagnesaemia, magnesium deficiency.
科研通智能强力驱动
Strongly Powered by AbleSci AI